Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin

Clinical Cardiology
T StörkR Müller

Abstract

At present there is little dispute that clinical tolerance of organic nitrates occurs during long-term treatment of patients with stable angina pectoris and congestive heart failure. Captopril exerts a favorable hemodynamic effect in coronary patients with heart failure who are clinically tolerant to nitroglycerin. Development of nitrate tolerance was observed during intravenous nitroglycerin treatment (10 mg/h) in 16 of 19 patients (7 women, 12 men; mean age 56 +/- 8 years) with coronary heart disease [stenosis > or = 75%, New York Heart Association (NYHA) classes II-III). The criterion applied was a loss of efficacy of at least 50% with regard to mean pulmonary capillary wedge pressure compared with the maximum effect of nitrate. The effect of captopril (50 mg p.o.) was determined in a blank test. Captopril (50 mg p.o.) was administered again at the stage of clinically manifest nitrate tolerance. Compared with the effect of captopril alone, significantly more pronounced reductions in mean pulmonary capillary wedge pressure (33% compared with 27%) and in mean pulmonary arterial pressure (36% compared with 17%) and significantly greater increases in cardiac index (14% compared with 7%) and stroke work index (34% compared with 1...Continue Reading

References

Oct 15, 1991·Biochemical and Biophysical Research Communications·M Feelisch, M Kelm
Oct 15, 1986·Biochemical Pharmacology·S A WaldmanF Murad
Sep 24, 1987·The New England Journal of Medicine·M PackerM Yushak
Sep 24, 1987·The New England Journal of Medicine·D C MayL D Hillis
Jan 15, 1988·JAMA : the Journal of the American Medical Association·J Abrams
Jun 1, 1994·Cardiovascular Drugs and Therapy·H L Fung, J A Bauer
Feb 19, 1993·Deutsche medizinische Wochenschrift·W D Bussmann, K Felsinger
May 30, 1996·The American Journal of Cardiology·T MünzelD G Harrison

❮ Previous
Next ❯

Citations

Sep 14, 2014·Heart Failure Clinics·Robert T ColeJaved Butler
Apr 10, 2004·The Journal of Clinical Hypertension·Gordon S Stokes
Mar 14, 2014·JACC. Heart Failure·Divya GuptaJaved Butler
Feb 25, 2018·Current Heart Failure Reports·Prabhjot SinghJaved Butler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.